11.07.2015 Views

Proceedings of the 5th International Symposium on EQUINE ...

Proceedings of the 5th International Symposium on EQUINE ...

Proceedings of the 5th International Symposium on EQUINE ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Equine Embryo TransferTABLE 1: Success rates <str<strong>on</strong>g>of</str<strong>on</strong>g> inducti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> ovulati<strong>on</strong> in Experiments 1 and 3Exp 1 (72 paired oestrous cycles) Exp 3 (60 paired oestrous cycles)Busereline Placebo P Busereline Busereline P40 µg x4 40 µg x4 20 µg x4Ovulati<strong>on</strong> within 48 hafter 1st injecti<strong>on</strong> 61% 22% < 0.00 183% 90% N.S.Ovulati<strong>on</strong> between 24and 48 h after1st injecti<strong>on</strong> 47% 14% < 0.054 7% 57% N.S.TABLE 2: success rates <str<strong>on</strong>g>of</str<strong>on</strong>g> inducti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> ovulati<strong>on</strong> in Experiment 4 and 5Exp 4 (50 paired oestrous cycles) Exp 5 (60 paired oestrous cycles)Busereline hCG P Busereline hCG P20 µg x 4 2500 ui 13.3 µg x 3 2500 uiOvulati<strong>on</strong> between32 and 48 hafter 1st injecti<strong>on</strong> 56 % 76 % N.S. 57 % 50 % N.S.Mean time <str<strong>on</strong>g>of</str<strong>on</strong>g>ovulati<strong>on</strong> ± sd 39.5 ± 3.1 h38.4 ± 2.5 h N.S .43.1 ± 2.1 h 37.7 ± 2.3 h < 0.01<str<strong>on</strong>g>of</str<strong>on</strong>g> ovulati<strong>on</strong> did not differ significantly between<str<strong>on</strong>g>the</str<strong>on</strong>g> 2 treatments (busereline 3 x 13.3 µg or hCG2,500 ui). However, <str<strong>on</strong>g>the</str<strong>on</strong>g>re were many earlysp<strong>on</strong>taneous ovulati<strong>on</strong>s within 32 h after <str<strong>on</strong>g>the</str<strong>on</strong>g> start<str<strong>on</strong>g>of</str<strong>on</strong>g> treatment quite <strong>on</strong>ly in cycles treated with hCG(11/30 versus 1/30). When ovulati<strong>on</strong> occurredbetween 32 and 48 h after <str<strong>on</strong>g>the</str<strong>on</strong>g> first or <str<strong>on</strong>g>the</str<strong>on</strong>g> <strong>on</strong>lyinjecti<strong>on</strong>, <str<strong>on</strong>g>the</str<strong>on</strong>g>re was a significant difference(P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!